- Home
- CATO vs PYXS Comparison
CATO vs PYXS Comparison
Compare CATO & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- PYXS
- Stock Information
- Founded
- CATO 1946
- PYXS 2018
- Country
- CATO United States
- PYXS United States
- Employees
- CATO N/A
- PYXS N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- PYXS Health Care
- Exchange
- CATO Nasdaq
- PYXS Nasdaq
- Market Cap
- CATO 88.2M
- PYXS 79.4M
- IPO Year
- CATO N/A
- PYXS 2021
- Fundamental
- Price
- CATO $4.32
- PYXS $2.85
- Analyst Decision
- CATO
- PYXS Strong Buy
- Analyst Count
- CATO 0
- PYXS 5
- Target Price
- CATO N/A
- PYXS $7.75
- AVG Volume (30 Days)
- CATO 48.0K
- PYXS 690.5K
- Earning Date
- CATO 11-20-2025
- PYXS 11-11-2025
- Dividend Yield
- CATO N/A
- PYXS N/A
- EPS Growth
- CATO N/A
- PYXS N/A
- EPS
- CATO N/A
- PYXS N/A
- Revenue
- CATO $650,830,000.00
- PYXS $2,820,000.00
- Revenue This Year
- CATO N/A
- PYXS N/A
- Revenue Next Year
- CATO N/A
- PYXS N/A
- P/E Ratio
- CATO N/A
- PYXS N/A
- Revenue Growth
- CATO N/A
- PYXS N/A
- 52 Week Low
- CATO $2.19
- PYXS $0.83
- 52 Week High
- CATO $6.70
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- CATO 52.43
- PYXS 73.77
- Support Level
- CATO $4.16
- PYXS $2.10
- Resistance Level
- CATO $4.67
- PYXS $2.78
- Average True Range (ATR)
- CATO 0.16
- PYXS 0.18
- MACD
- CATO -0.05
- PYXS 0.02
- Stochastic Oscillator
- CATO 23.90
- PYXS 77.16
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.